A focused 2026 clinical landscape deep dive into JPRN-jRCT2033260314, evaluating Investigational Regimen in Hemophilia B: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.

A focused 2026 clinical landscape deep dive into NCT07704684, evaluating Sacubitril in Essential Hypertension: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.

A focused 2026 clinical landscape deep dive into NCT07704697, evaluating Sacubitril in Essential Hypertension: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.

A focused 2026 clinical landscape deep dive into ChiCTR2600128203, evaluating Sigvotatug vedotin in Non-Small Cell Lung Cancer: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.

A focused 2026 clinical landscape deep dive into NCT07706582, evaluating Iron Dextran in Kidney Failure: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.

A focused 2026 clinical landscape deep dive into ChiCTR2600128248, evaluating hyperbaric oxygen therapy in Metastatic breast cancer: design, endpoints, sponsor context, readout timing and white space.

A focused 2026 clinical landscape deep dive into NCT07704177, evaluating Trastuzumab Rezetecan in HER2 positive adenocarcinoma of biliary tract: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.

A focused 2026 clinical landscape deep dive into NCT07704164, evaluating Colchicine in Arteritis: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.

A focused 2026 clinical landscape deep dive into ChiCTR2600128257, evaluating a standardized surgical hemostasis checklist in liver cancer resection: design, endpoints, sponsor context, readout timing and white space.

Immunovant 2026 BD opportunity scan: pipeline assets, transaction precedents, financial signals, IP-risk flags, and a prioritized partnering shortlist.

A focused 2026 clinical landscape deep dive into JPRN-jRCT2071260059, evaluating Investigational Regimen in Post-essential thrombocythemia myelofibrosis: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space

A focused 2026 clinical landscape deep dive into NCT07705022, evaluating Dexmedetomidine Hydrochloride in Consciousness: trial design, endpoint strategy, sponsor context, benchmark readouts and development white space.